TRIP13 and gastric adenocarcinoma: Several studies have discussed the candidacy of TRIP13 in the carcinogenesis of other neoplasms (Banerjee et al. 2014; Larkin et al. 2012; Sheng et al. 2018), and Lu and colleagues (Lu et al. 2019a, b) observed the elevation of TRIP13 expression in gastric adenocarcinoma.